By delivering this special New Year Edition of the OncoWuXi Newsletter, we would like to extend our sincere appreciation for your continued interest in OncoWuXi database, and wish you a happy, healthy and prosperous New Year! This Special Edition will bring you our full-year database overview on target identification and validation, biomarker, targeted oncology, immuno-oncology, and immunology platforms.

It has been our pleasure to collaborate with you throughout the year and with a deep gratitude for your continued trust and support, we look forward to serving you again in 2022!

  • CRISPR/Cas9 library-based in vitro & in vivo screening
  • 280+ CDX models in mouse
  • 20+ CDX models in rat
  • 30+ Orthotopic models
  • 30+ Metastasis models
  • 1300+ PDX models
  • 90+ Drug-resistant models
  • 40+ Autoimmune disease models
  • GEAM & AAV packaging
  • Rare genetic disease models

  • 70+ Syngeneic models
  • 70+ Humanized models
  • 30+ Immune assays
  • NHP translation Center
  • Multiplex pathology analysis
  • NanoString, scRNAseq, spatial transcriptomics platform
  • CAP Pathology & FACS lab
  • 200+ Clinical biomarkers